Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teruhiko Shimokawa

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The FEBS Journal|January 5, 2011
Adipocyte hyperplasia and RMI1 in the treatment of obesityAkira Suwa, Takeshi Kurama, Teruhiko Shimokawa
Expert Opinion on Therapeutic Targets|June 12, 2010
SHIP2 and its involvement in various diseasesAkira Suwa, Takeshi Kurama, Teruhiko Shimokawa
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2002
Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptidesTeruhiko Shimokawa, Monica V Kumar, M Daniel Lane
Endocrine|March 25, 2011
Glucose regulates RMI1 expression through the E2F pathways in adipose cellsAkira Suwa, Masayasu Yoshino, Takeshi Kurama, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2002
Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese miceMonica V Kumar, Teruhiko Shimokawa, Tim R Nagy, et al.
Biochemical and Biophysical Research Communications|August 7, 2002
Effects of low-intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscleShin Terada, Masahide Goto, Miyuki Kato, et al.
European Journal of Pharmacology|June 19, 2010
Glucose metabolism activation by SHIP2 inhibitors via up-regulation of GLUT1 gene in L6 myotubesAkira Suwa, Takeshi Kurama, Tadashi Yamamoto, et al.
European Journal of Pharmacology|July 27, 2010
Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db miceHirotsugu Tanaka, Takeyuki Nagashima, Akiyoshi Shimaya, et al.
Life Sciences|February 1, 2011
Enhanced insulin secretion and sensitization in diabetic mice on chronic treatment with a transient receptor potential vanilloid 1 antagonistHirotsugu Tanaka, Akiyoshi Shimaya, Tetsuo Kiso, et al.
Journal of Biochemistry|September 3, 2002
Myonase is localized in skeletal muscle myofibrilsShinichiro Hori, Makoto Yamada, Sachiko Ohtani, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The FEBS Journal|January 5, 2011
Adipocyte hyperplasia and RMI1 in the treatment of obesityAkira Suwa, Takeshi Kurama, Teruhiko Shimokawa
Expert Opinion on Therapeutic Targets|June 12, 2010
SHIP2 and its involvement in various diseasesAkira Suwa, Takeshi Kurama, Teruhiko Shimokawa
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2002
Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptidesTeruhiko Shimokawa, Monica V Kumar, M Daniel Lane
Endocrine|March 25, 2011
Glucose regulates RMI1 expression through the E2F pathways in adipose cellsAkira Suwa, Masayasu Yoshino, Takeshi Kurama, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2002
Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese miceMonica V Kumar, Teruhiko Shimokawa, Tim R Nagy, et al.
Biochemical and Biophysical Research Communications|August 7, 2002
Effects of low-intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscleShin Terada, Masahide Goto, Miyuki Kato, et al.
European Journal of Pharmacology|June 19, 2010
Glucose metabolism activation by SHIP2 inhibitors via up-regulation of GLUT1 gene in L6 myotubesAkira Suwa, Takeshi Kurama, Tadashi Yamamoto, et al.
European Journal of Pharmacology|July 27, 2010
Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db miceHirotsugu Tanaka, Takeyuki Nagashima, Akiyoshi Shimaya, et al.
Life Sciences|February 1, 2011
Enhanced insulin secretion and sensitization in diabetic mice on chronic treatment with a transient receptor potential vanilloid 1 antagonistHirotsugu Tanaka, Akiyoshi Shimaya, Tetsuo Kiso, et al.
Journal of Biochemistry|September 3, 2002
Myonase is localized in skeletal muscle myofibrilsShinichiro Hori, Makoto Yamada, Sachiko Ohtani, et al.
Pageof 2